The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback